Beverly Ann Karpman, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8630 |
Todd Feinman, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1532 Penmar Ave, Venice, CA 90291 Phone: 310-450-6519 Fax: 310-399-4787 |
Dr. Robert Joel Heller, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1126 Rose Ave, Venice, CA 90291 Phone: 310-480-0177 Fax: 310-933-0243 |
Arthur K. Huberman, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636 |
Dr. Jose Quiroga, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636 |
Dr. Gary A. Richwald, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 5th Ave, Venice, CA 90291 Phone: 310-396-2200 Fax: 310-664-9666 |
Charles Cuong Quoc Huynh, D.O. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636 Fax: 310-392-6642 |
Dr. Gilmore Chung, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 604 Rose Ave, Venice, CA 90291 Phone: 310-392-8636 Fax: 310-392-6642 |
News Archive
Many parents and caregivers believe that multi-sensory stimulation during infancy promotes developmental growth and learning, but researchers who conducted eye movement experiments on preverbal infants show that this is not always true.
Using the same expertise they've employed to build new organs for patients, scientists at Wake Forest Institute for Regenerative Medicine and colleagues have engineered micro hearts, lungs and livers that can potentially be used to test new drugs. By combining the micro-organs in a monitored system, the researchers aim to mimic how the human body responds to medications.
New research overturns a myth that has persisted for nearly four decades - that competing in endurance sports, like this weekend's London Marathon, suppresses the body's immune system and makes competitors more susceptible to infections.
Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.
Helicos BioSciences Corporation, today announced the sale of a Helicos® Genetic Analysis System to a collaborative Dutch research group led by the Leiden University Medical Center (LUMC), further including the medical centers of Amsterdam (AMC) Groningen (UMCG) and Rotterdam (Erasmus MC) and funded by a grant from NWO, the Netherlands Organization of Scientific Research.
› Verified 3 days ago